Senior Medical Director, Treatment - Global Medical Affairs, ViiV

Purpose

Provide senior global medical leadership for the long-acting HIV portfolio, with primary accountability for an emerging treatment programme and its evidence, communication and launch-readiness agenda. Establish the global medical and scientific strategic direction, short- and long-term goals, and the overall planning and delivery of integrated medical affairs plans for the next-generation long-acting treatment portfolio. Work in close partnership with the broader long-acting franchise to ensure a coherent, joined-up medical strategy across the portfolio. Collaborate across current and future long-acting and combination assets to maximise the collective value of the franchise and support a seamless scientific narrative across treatment and prevention. Build and develop a global medical capability to support the evolving portfolio, with responsibility for leading and developing a team of up to four professionals over time. Operate effectively within a complex, highly matrixed environment, navigating uncertainty and shaping strategy as the scientific, competitive and policy landscapes evolve. Ensure ViiV Healthcare’s scientific and medical data are leveraged effectively and communicated in a fair, balanced and compliant manner in line with ABPI/PMCPA and other applicable codes. Partner across Clinical, Statistics, Regulatory, Safety, Commercial, Market Access, Policy, Scientific Communications and Compliance to shape the pipeline evidence strategy and support responsible commercialisation.

Accountabilities

• Global medical accountability for an emerging pipeline treatment programme.
• Partnership with the established long-acting treatment organisation to ensure alignment of strategy, evidence generation, scientific communications and lifecycle planning across the portfolio.
• Cross-franchise influence across current and future long-acting / combination assets.
• Decision rights over pipeline medical strategy, evidence prioritisation and scientific positioning, in partnership with the Global Medical Lead.
• Influence over launch-readiness, resistance/pharmacology strategy and cross-functional evidence governance.

Responsibilities

• Set and own the integrated global medical strategy and integrated evidence plan for the emerging pipeline treatment, spanning pre-launch to post-launch phases.
• Work in partnership with the established long-acting treatment team to create an aligned medical strategy, integrated evidence plan and coherent scientific narrative across the treatment portfolio.
• Build, develop and lead a high-performing global medical capability to support the long-acting treatment pipeline, with responsibility for up to four direct reports as the organisation and portfolio evolve.
• Demonstrate strong collaborative leadership, build alignment across functions, and deliver effectively amid ambiguity, changing priorities and emerging evidence.
• Work directly with other long-acting franchise leads to ensure a joined-up franchise medical strategy and consistent external scientific positioning.
• Shape and oversee the pipeline evidence agenda, including Phase IIIb/IV studies, investigator-sponsored research, resistance and pharmacology strategy, and real-world and service-delivery evidence, in partnership with Clinical, Statistics and R&D.
• Build and maintain effective relationships with external experts, HCPs, guideline bodies and communities, providing senior scientific expertise and facilitating medical scientific team engagement on long-acting treatment.
• Ensure the scientific quality and compliance of all medical and promotional activities for the pipeline, acting as senior medical reviewer/signatory where appropriate, and proactively identifying and mitigating ABPI/PMCPA risk.
• Partner with Scientific Communications to define and deliver the scientific platform, narrative and communication plan for long-acting treatment, ensuring consistency across regions.
• Provide senior medical input to launch readiness, market access and commercial planning for pipeline assets, translating clinical differentiation into credible, evidence-based value messages.
• Represent ViiV in senior internal governance and external scientific forums, advising leadership on the medical implications of the evolving long-acting treatment landscape and competitive environment.

Basic Qualifications

• MD, PharmD or PhD in a medical / scientific discipline or public health
• Experience of working in the HIV or infectious disease therapy